Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Total Non-Current Liabilities: 2014-2025

Historic Total Non-Current Liabilities for CytomX Therapeutics (CTMX) over the last 7 years, with Sep 2025 value amounting to $46.6 million.

  • CytomX Therapeutics' Total Non-Current Liabilities fell 70.60% to $46.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.6 million, marking a year-over-year decrease of 70.60%. This contributed to the annual value of $116.9 million for FY2024, which is 52.36% down from last year.
  • Per CytomX Therapeutics' latest filing, its Total Non-Current Liabilities stood at $46.6 million for Q3 2025, which was down 8.53% from $50.9 million recorded in Q2 2025.
  • CytomX Therapeutics' Total Non-Current Liabilities' 5-year high stood at $294.0 million during Q2 2023, with a 5-year trough of $46.6 million in Q3 2025.
  • Its 3-year average for Total Non-Current Liabilities is $165.0 million, with a median of $172.4 million in 2024.
  • Data for CytomX Therapeutics' Total Non-Current Liabilities shows a maximum YoY plummeted of 72.70% (in 2025) over the last 5 years.
  • CytomX Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $245.3 million in 2023, then plummeted by 52.36% to $116.9 million in 2024, then crashed by 70.60% to $46.6 million in 2025.
  • Its Total Non-Current Liabilities was $46.6 million in Q3 2025, compared to $50.9 million in Q2 2025 and $69.3 million in Q1 2025.